The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive clinical characteristics and ctDNA mutational profile analysis of endocrine resistance/sensitivity to adjuvant ET therapy in luminal breast cancer from the GEICAM/2014-03_RegistEM registry.
 
Angel Guerrero
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Novartis; Pfizer; Pierre Fabre; Seagen
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Pierre Fabre; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Novartis; Pfizer; Pierre Fabre
 
Isabel Alvarez
Consulting or Advisory Role - Gilead Sciences; MSD; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; MSD; Pfizer
 
Silvia Antolín Novoa
No Relationships to Disclose
 
Josefina Cruz Jurado
Consulting or Advisory Role - AstraZeneca; Bayer; DAICHII; Deciphera; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Roche; seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; deciphera; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; DAICHII; Gilead Sciences; Lilly; Novartis; PharmaMar; Pierre Fabre
 
CESAR Augusto Rodriguez Sanchez
No Relationships to Disclose
 
Purificacion Martinez
No Relationships to Disclose
 
Catalina Falo
No Relationships to Disclose
 
María Hernández-Sosa
Honoraria - AstraZeneca/Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Seagen
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Pfizer
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Pfizer; Roche
 
Mireia Margelí
Consulting or Advisory Role - Daiichi Sankyo; Gylead; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca (Inst); Eisai (Inst); Gylead (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
 
Iria Gonzalez Maeso
Travel, Accommodations, Expenses - Merck; Novartis
 
Álvaro Rodríguez- Lescure
Consulting or Advisory Role - AstraZeneca Spain; DAICHII-SANKYO; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SEAGEN
Speakers' Bureau - AstraZeneca Spain; DAICHII-SANKYO; Lilly; Novartis; Pfizer; Roche; SEAGEN
Research Funding - AstraZeneca Spain (Inst); BRISTOL-MYERS SQUIBB (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Maria Marin Alcalá
No Relationships to Disclose
 
Antonio Anton
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Gilead Sciences; Lilly
Speakers' Bureau - Daiichi Sankyo/Lilly; Lilly; Pfizer
Expert Testimony - Pfizer
 
Silvia Varela Ferreiro
Honoraria - Lilly, MSD, Pzifer
Consulting or Advisory Role - Lilly, MSD, Pzifer
Speakers' Bureau - Lilly, MSD, Pzifer
Travel, Accommodations, Expenses - Lilly, MSD
 
Jesús Herranz
No Relationships to Disclose
 
Rosalia Caballero
No Relationships to Disclose
 
Daniel Fernández García
Employment - Almirall (I); Exonate (I)
Stock and Other Ownership Interests - AMADIX; Exonate (I)
Research Funding - Almirall (I); Exonate (I)
 
Ariadna Tibau
Honoraria - Lilly; Novartis; Novartis; Roche/Genentech
Consulting or Advisory Role - Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Novartis
 
Sara Lopez-Tarruella Cobo
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Gebro Pharma; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Veracyte
Travel, Accommodations, Expenses - AstraZeneca Spain; Gilead Sciences; Pfizer
 
Federico Gustavo Rojo Todo
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; GlaxoSmithKline; Lilly; Menarini; Merck; MSD; Novartis; Roche
Research Funding - AstraZeneca; Menarini